Role of haemoglobin in the protection of cultured lymphocytes against diepoxybutane (DEB), assessed by in vitro induced chromosome breakage. by PORTO, B. et al.
Mutation Research 536 (2003) 61–67
Role of haemoglobin in the protection of cultured
lymphocytes against diepoxybutane (DEB),
assessed by in vitro induced chromosome breakage
Beatriz Porto a,∗, Laura Chiecchio a, Jorge Gaspar b, Ana Faber b,
Luciana Pinho c, José Rueff b, Isabel Malheiro a
a Laboratory of Cytogenetics, Instituto Cieˆncias Biomédicas Abel Salazar (ICBAS), Largo do Prof. Abel Salazar,
No. 2, 4099-003 Porto, Portugal
b Department of Genetics, Faculty of Medical Sciences, Universidade Nova de Lisboa (UNL), Rua da Junqueira,
No. 96, 1349-008 Lisboa, Portugal
c Service of Haematology, Hospital Geral de Santo António (HGSA), Largo do Prof. Abel Salazar, No. 2, 4099-003 Porto, Portugal
Received 19 October 2001; received in revised form 7 January 2003; accepted 10 January 2003
Abstract
Diepoxybutane (DEB) is an alkylating agent that can be used to assess chromosome instability in repair-deficient subjects.
Previous authors investigated the role of red blood cells (RBC) in determining individual susceptibility to DEB in normal
healthy donors, and demonstrated that a polymorphic enzyme in RBC, Glutathione S-transferase T1 (GSTT1), is involved
in DEB detoxification. In the present work we studied the influence of individual GSTM1 and GSTT1 genotypes and the
presence of RBC on the frequency of DEB-induced chromosome breakage in lymphocyte cultures from normal individuals
and, in particular, the influence of isolated components of RBC: RBC membranes, RBC lysate, and haemoglobin. Our results
confirm that individual GSTT1 genotypes modulate the level of genetic lesions induced by DEB; however, this effect was
not sufficient to explain the highly significant variation in chromosome breakage between whole blood and RBC-depleted
cultures. We showed that RBC can protect cultured lymphocytes against chromosome breakage induced by DEB and we
demonstrated the particular role of haemoglobin in the protective effect.
© 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Diepoxybutane (DEB) is a bifunctional alkylating
agent that can induce chromosome breakage in lym-
phocyte cultures. This effect can be used to discrim-
inate patients with Fanconi anaemia (FA), i.e. one of
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the cancer-prone chromosome instability syndromes
that is characterized by a hypersensitivity to DNA
cross-linking agents, such as DEB [1,2]. In fact, the
low clastogenic effect of a nontoxic concentration of
DEB in normal individuals, and even in other chro-
mosome instability syndromes (for example, ataxia
telangiectasia, xeroderma pigmentosum and Bloom’s
syndrome), is highly increased in FA patients [1–5].
Even so, the response of lymphocytes to the induction
of sister chromatid exchanges (SCE) and chromosome
1383-5718/03/$ – see front matter © 2003 Elsevier Science B.V. All rights reserved.
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aberrations (CA) by DEB at low doses can be variable
among normal individuals. In previous studies [6–9],
it was shown that a subgroup of normal donors is char-
acterized by higher frequencies of DEB-induced SCE
and CA than other donors. Consequently, donors can
be divided into two distinct patterns of cytogenetic re-
sponsiveness: low-respondents and high-respondents.
It was suggested that this bimodal distribution could
be due to a factor responsible for the “sensitive” phe-
notype. Landi et al. [10] demonstrated that red blood
cells (RBC) and plasma factors are involved in deter-
mining the sensitivity of lymphocytes to DEB-induced
SCE and CA. Norppa et al. [8] described the role of
the GSTT1 gene (expressed in RBC) in determining
the individual sensitivity to DEB. More recently it was
confirmed that the presence of the GSTT1 gene re-
duces the relative sensitivity of the lymphocytes to the
induction of SCE and CA by DEB [11–14]. However,
although most of the variation in SCE frequency can
be explained by GSTT1 genotype, other factors than
GSTT1 may be important in determining DEB sensi-
tivity measured by CA.
In order to further investigate possible specific fac-
tors that can contribute to modulation of the genotox-
icity induced by DEB, in the present work we studied
the influence of individual GSTM1 and GSTT1 geno-
types and the presence of RBC on the frequency of
DEB-induced chromosome breakage in lymphocyte
cultures from normal individuals and, in particular, the
influence of isolated components of RBC: RBC mem-
branes, RBC lysate, and haemoglobin.
2. Materials and methods
2.1. Subjects
The study group consisted of 20 normal healthy
blood donors (11 males and 9 females) with an age
range from 23 to 46 years. None of the controls had
been exposed to drugs. All procedures were done with
the informed consent of the participants.
2.2. Cells and cell cultures
From each individual 10 ml of heparinized blood
was collected by venipuncture. Samples of whole
blood and blood depleted of RBC by gravity sedi-
mentation (total leukocytes) were used in cultures.
RBC suspensions were obtained from whole blood
after centrifugation at 2000 rpm and rinsed twice with
RPMI medium. RBC membrane and lysate suspen-
sions were obtained as follows: sterile distilled H2O
was added to packed RBC (1 ml RBC/2 ml H2O);
this suspension was refrigerated (−4 ◦C) during
15 min; after centrifugation (1400 rpm, 10 min), the
lysate (the supernatant containing haemoglobin) was
RBC-depleted from the membranes (the pellet, rinsed
twice with lysis solution). Lysate and membrane sus-
pensions were reconstituted with RPMI to a final
concentration equal to the initial RBC concentration.
Whole blood (0.5 ml) or RBC-depleted leukocytes
(at the same cell concentration as determined in the
0.5 ml of whole blood) were cultured in RPMI com-
plete medium supplemented with 15% FCS and antibi-
otics. Cultures were stimulated with 5g/ml of PHA
and placed in an incubator at 37 ◦C with a 5% CO2 at-
mosphere for 72 h. DEB ((±)-1,2:3,4-diepoxybutane,
[298-18-0], D-7019 Lot 34H3683, Sigma), at a final
concentration in the medium of 0.05 or 0.1g/ml, was
added to the cultures 24 h after their initiation, thus
exposing cells to the chemical for 48 h. Since DEB
is a suspected carcinogen with unknown risk, appro-
priate precautions were taken. Cultures were handled
using gloves, and all work was done in a vertical lam-
inar flow hood (for culture procedures and the first
part of the harvest procedure). Since DEB is rapidly
inactivated by concentrated hydrochloric acid (HCl),
all disposable culture bottles and pipettes were rinsed
with HCl before being discarded.
In the appropriate experiments, autologous or het-
erologous RBC were added at a RBC-leukocyte ra-
tio of 100:1, RBC membranes and RBC lysate were
added at the same concentration as RBC, and purified
ferrous haemoglobin (Hg-A0, Sigma) was added at an
initial concentration of 10 mg/ml RBC.
2.3. Cytogenetic analysis
After 3 days of culture, cells were harvested af-
ter 1 h incubation with colchicine (4g/ml) followed
by hypotonic treatment with 75 mM KCl and fixed in
a 1:3 solution of acetic acid:methanol. Chromosome
preparations were made following standard methods.
Analysis was performed on 50–100 (mode = 100)
Giemsa-stained metaphases from each preparation.
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Only when the mitotic index was very low and
the number of breaks was high, a minimum of 25
metaphases was counted. To avoid bias in cell se-
lection, consecutive metaphases which appeared un-
broken and with sufficient well-defined chromosome
morphology were selected for study. Each cell was
scored for chromosome number and the number and
types of structural abnormalities. Achromatic areas
less than a chromatid in width were scored as gaps
while those more than a chromatid in width were
scored as breaks. Chromatid exchange configura-
tions (triradials and quadriradials), translocations,
dicentrics and ring chromosomes were scored as re-
arrangements. Gaps were excluded in the calculation
of chromosome breakage frequencies, and rearrange-
ments were scored as two breaks.
2.4. DNA extraction
Blood samples from 12 individuals were col-
lected into 10 ml heparinized tubes and stored at
−20 ◦C until use. Genomic DNA was obtained from
250l of whole blood using a commercially avail-
able kit according to the manufacturer’s instructions
(QIAamp DNA extraction kit; Qiagen, Hilden, Ger-
many). Each DNA sample was stored at −20 ◦C until
analysis.
2.5. Genotyping
GSTM1 and GSTT1 genotyping for gene deletions
was carried out by a multiplex PCR as described by
Lin et al. [15] with the modifications described by
Teixeira et al. [16]. All the genotype determinations
were carried out twice in independent experiments and
all the inconclusive samples were reanalyzed.
2.6. Statistical analysis
The Kolmogorov–Smirnov test was used in order to
verify the normality of the continuous variables and
the Levene test was used to analyze the homogeneity
of variances. Since the results obtained by these meth-
ods showed that the data distributions were normal and
the associated variances homogeneous, the statistical
analysis was performed with SPSS statistical package
(version 11) (SPSS, Inc., Chicago, IL).
3. Results
3.1. Influence of RBC, GSTM1 and GSTT1 on the
frequency of chromosome breakage in DEB-treated
lymphocyte cultures
The presence of chromosome breaks in a series
of DEB-treated lymphocyte cultures from each of
12 individuals was determined, and a comparison
was made between different types of cultures: whole
blood cultures, cultures of RBC-depleted leukocytes,
cultures of RBC-depleted leukocytes to which autolo-
gous RBC were added and cultures of RBC-depleted
leukocytes to which heterologous RBC were added.
As shown in Table 1, the frequency of cells with
breaks was significantly higher in cultures with-
out RBC (RBC-depleted leukocytes) than in whole
blood cultures (P = 5.29E-05). No significant dif-
ference was observed in the frequency of cells with
breaks between whole blood cultures and cultures
of RBC-depleted leukocytes where autologous RBC
were added (P = 0.3371). However, when het-
erologous RBC were added a significant decrease
in the frequency of breaks was observed (P =
0.0069).
Our results also show that individual GSTM1 geno-
types have no effect on the frequency of DEB-induced
chromosome breaks, but GSTT1 genotypes modulate
the level of genetic lesions induced by DEB. In fact,
in the experiments depicted in Table 1, a significant
difference between GSTT1 ‘null’ and ‘non-null’ indi-
viduals was observed in experiments with whole blood
(7.35 ± 1.85 versus 4.79 ± 1.85, respectively; P =
0.016) and in leukocytes supplemented with autolo-
gous RBC (7.83 ± 1.84 versus 4.16 ± 1.88, respec-
tively; P = 0.008), but this effect was not observed
in the experiments carried out in cultured leukocytes
(26.63 ± 19.27 versus 33.93 ± 12.92, respectively;
P = 0.448) and in cultured leukocytes in the pres-
ence of heterologous RBC (3.13±0.85 versus 3.89±
2.15, respectively; P = 0.518); it is important to note
that all the heterologous RBC used were from GSTT1
‘non-null’ individuals. Despite the observed effect of
GSTT1 genotype in the modulation of genetic dam-
age induced by DEB, a significantly higher frequency
of chromosome breaks was observed in RBC-depleted
cultures (31.49± 14.89) compared with whole blood
cultures from GSTT1 null individuals (7.35 ± 1.85)
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Table 1
Chromosome breakage in DEB-treated (0.05g/ml) peripheral blood lymphocytes from 12 normal healthy donors: cultures of whole blood
(a), RBC-depleted leukocytes (b), RBC-depleted leukocytes to which autologous red blood cells (RBC) were added (c) and RBC-depleted
leukocytes to which heterologous RBC were added (d)
Donor Frequency of cells with chromosome breaks (%)
Code no. Genotype Whole blood (a) Leukocytes (b) Leukocytes + aut RBC (c) Leukocytes + het RBC (d)
1 M0T0 9.4 24.5 6.0 3.0
2 M+T0 8.0 7.4 10.3 4.0
3 M+T0 7.0 53.3 8.0 3.5
4 M+T0 5.0 21.3 7.0 2.0
5 M0T+ 6.0 24.5 6.0 6.0
6 M0T+ 5.0 32.1 3.0 1.1
7 M0T+ 3.3 48.7 1.0 4.0
8 M+T+ 6.0 44.4 5.0 3.2
9 M+T+ 6.0 30.6 5.0 4.0
10 M+T+ 5.0 47.6 3.0 3.0
11 M+T+ 4.0 33.0 4.0 2.0
12 M+T+ 3.0 10.5 6.3 7.8
Mean 5.64 ± 1.87 31.49 ± 14.85 5.38 ± 2.49 3.63 ± 1.81
The genotype of genes GSTT1 and GSTM1 was determined for each donor. M+: GSTM1 non-null; M0: GSTM1 null; T+: GSTT1 non-null;
T0: GSTT1 null. t-test: (a) vs. (b), P = 5.29E-05; (a) vs. (c), P = 0.3371; (a) vs. (d), P = 0.0069.
(P = 0.0048). So, other factors may also be involved
in DEB detoxification.
In order to know if RBC concentration had an influ-
ence on the frequency of DEB-induced chromosome
breaks, a serial study was performed of lymphocyte
cultures from one individual with different concen-
trations of RBC (Table 2). Our results show that, for
the same leukocyte concentration, there was a de-
crease in the frequency of chromosome breaks pro-
portional to the increase in RBC concentration. In
fact, the number of cells with breaks obtained at the
DEB dose of 0.05g/ml perfectly regresses on the
Table 2
Influence of red blood cell (RBC) concentration on chromosome breakage in DEB-treated peripheral blood lymphocyte cultures from one
normal healthy donor (no. 13)
Cell cultures DEB: 0.05g/ml DEB: 0.1g/ml
No. of cells with
breaks (%)
No. of breaks per
cell
No. of cells with breaks (%) No of breaks per cell
WB (0.25 ml RBC) 0 0.00 3 0.04
LEUK + 0.2 ml RBC 2 0.02 13 0.30
LEUK + 0.1 ml RBC 4 0.07 11 0.16
LEUK + 0.05 ml RBC 9 0.12 20 0.32
LEUK + 0.025 ml RBC 26 0.32 50 1.21
LEUK (0.3 ml LEUK) 27 0.36 No dividing cells No dividing cells
All cultures have the same leukocyte concentration. WB: whole blood cultures; LEUK: cultures of RBC-depleted leukocytes.
reciprocal of the amount of RBC added to the incu-
bation mixture (slope coefficient P = 0.0009, r2 =
0.9837).
The effect of the addition of old RBC was also
tested in DEB-treated lymphocyte cultures from two
normal individuals (blood donors 14 and 15). It was
observed that, while in whole blood cultures the fre-
quency of cells with breaks was 4% (in both individ-
uals), in cultures of RBC-depleted leukocytes where
old RBC (aged during 4 weeks) were added that fre-
quency increased to 44.1% in one individual and to
11% in the other.
B. Porto et al. / Mutation Research 536 (2003) 61–67 65
Table 3
Chromosome breakage in DEB-treated (0.05g/ml) peripheral blood lymphocytes from three normal healthy donors: cultures of whole
blood (a), RBC-depleted leukocytes (b), RBC-depleted leukocytes to which isolated membranes of red blood cells (RBC) were added (c)
and RBC-depleted leukocytes to which RBC lysate was added (d)
Donor no. Frequency of cells with chromosome breaks (%)
Whole blood (a) Leukocytes (b) Leukocytes + RBC membrane (c) Leukocytes + RBC lysate (d)
16 11.1 49.0 42.9 13.0
17 8.7 58.0 56.0 7.4
18 4.0 28.0 27.0 4.0
Mean 7.93 ± 3.61 45.00 ± 15.39 41.97 ± 14.52 8.13 ± 4.54
t-test: (a) vs. (b), P = 0.018467023; (c) vs. (d), P = 0.0237399; (a) vs. (c), P = 0.416024825; (b) vs. (d), P = 0.095663364.
3.2. Influence of isolated components of RBC
on the frequency of chromosome breakage in
DEB-treated lymphocyte cultures
In order to ascertain if isolated components of
RBC had an influence on the frequency of DEB-
induced chromosome breaks, several experiments
involving blood components were carried out, as
follows.
In a first experiment we determined the frequency
of cells with breaks in a series of DEB-treated lym-
phocyte cultures from each of three individuals,
and a comparison was made between the different
types of culture: whole blood cultures, cultures of
RBC-depleted leukocytes, cultures of RBC-depleted
leukocytes to which isolated RBC membranes were
added and cultures of RBC-depleted leukocytes to
which RBC lysate was added. As shown in Table 3,
the frequency of cells with breaks was significantly
higher in cultures without RBC (RBC-depleted leuko-
cytes) than in whole blood cultures (P = 0.018467).
This result corroborates the data shown in Table 1.
As to the isolated blood components, the results
show that the frequency of cells with breaks was
significantly higher in leukocyte cultures where RBC
membranes were added compared with leukocyte cul-
tures where RBC lysate was added (P = 0.023740).
Besides, we observed that there was no significant
difference between the frequency of cells with breaks
in cultures of whole blood and cultures of leuko-
cytes were RBC lysate was added (P = 0.416025).
Accordingly, there was no significant difference
between the frequency of cells with breaks in cul-
tures of RBC-depleted leukocytes and cultures of
leukocytes were RBC membranes were added (P =
0.095663).
In order to evaluate if, in the RBC lysate, the
haemoglobin could influence the frequency of chro-
mosome breaks in DEB-treated lymphocyte cultures,
a second set of experiments was performed, with the
following types of cultures: whole blood cultures,
cultures of RBC-depleted leukocytes, and cultures of
RBC-depleted leukocytes to which haemoglobin (Hb)
was added. As shown in Table 4, the addition of Hb
to RBC-depleted leukocyte cultures of both donors 19
and 20 resulted in a decrease in chromosome break-
age similar to that observed in whole blood cultures;
besides, for donor 20 this decrease was proportional
to Hb concentration, i.e. the frequency of cells with
breaks and the number of breaks per cell were in-
versely proportional to the RBC concentration.
Table 4
Chromosome breakage in DEB-treated (0.05g/ml) peripheral
blood lymphocytes from two normal healthy donors: cultures
of whole blood (WB), RBC-depleted leukocytes (LEUK), and
RBC-depleted leukocytes to which haemoglobin (Hb) was added
Donor
no.
Cell cultures No. of
cells with
breaks (%)
No. of
breaks
per cell
19 WB 9 0.10
LEUK 34 0.57
LEUK + Hb (10 mg/ml RBC) 19 0.30
20 WB 18 0.20
LEUK 28 0.44
LEUK + Hb (5 mg/ml RBC) 16 0.24
LEUK + Hb (10 mg/ml RBC) 14 0.22
LEUK + Hb (20 mg/ml RBC) 11 0.14
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4. Discussion
The response of lymphocytes to the genotoxic ef-
fects of DEB has been extensively studied, not only
because this drug can be used to discriminate pa-
tients with Fanconi anemia but also because there
is a marked inter-individual variability in DEB re-
sponsiveness among normal individuals. The results
obtained in the present study confirm and extend the
data obtained by Landi et al. [10] on the effect of
RBC in determining the sensitivity of an individual’s
lymphocytes to DEB. In fact, the presence of RBC
decreased the frequency of chromosome breakage
in DEB-treated whole blood cultures from normal
donors, when compared with DEB-treated cultures
of RBC-depleted leukocytes. Furthermore, when iso-
lated components of RBC were added to the cultures
of RBC-depleted leukocytes, we observed that the
addition of Hb, and not membranes, resulted in a
decrease of chromosome breakage similar to that
observed in whole blood cultures.
It is known that RBC contain complex enzyme
systems that are involved in the protection of its main
components, Hb and membrane, against oxidative
stress [17–19]. RBC are also capable of metabolizing
certain drugs and chemicals. In fact, they contain high
concentrations of reduced glutathione and glutathione
transferases, which participate in the local detoxifi-
cation of various drugs and chemicals which could
damage Hb and membranes [20–22]. This property of
RBC has been used as a source of metabolic activa-
tion in in vitro toxicology studies [23]. In the present
study the results suggest that RBC, besides its in-
volvement in the protection of its main components,
are involved in the protection of lymphocytes against
DEB toxicity, and possibly other cell systems not yet
studied.
When we tested the role of isolated RBC com-
ponents in the protection of cultured lymphocytes
against DEB we observed that membranes alone
can not protect lymphocytes in the same way that
RBC protect. Conversely, haemoglobin alone has a
protective role similar to that of RBC. The role of
haemoglobin in the protection of lymphocytes against
SCE induced by styrene was already suggested by
Norppa et al. [24]. They showed that the induction of
SCE by styrene in whole blood lymphocyte cultures
of several donors was dependent on the presence
of RBC, and it was suggested that this activation
is the result of a conversion of styrene into styrene
7,8-oxide by oxy-haemoglobin. In the present work
we showed the role of haemoglobin in the protec-
tion of lymphocytes against chromosomal breakage
induced by DEB. In fact, the observations described
in Tables 2 and 4 suggest that the protection effect
of haemoglobin is a function of its concentration.
Therefore, the haemoglobin concentration plays a
definite and quantifiable role and the amount should
be carefully taken into account when estimating the
clastogenic activity of DEB at the individual level.
All these findings have important practical implica-
tions, since the large inter-individual differences in
RBC and haemoglobin concentrations or types can
modulate the response of lymphocytes to the toxic ef-
fect of DEB. Patients with Fanconi anemia, who have
their diagnosis based on a DEB-test for chromosomal
breakage detection, are characterized by a high level
of fetal haemoglobin, and so the specific role of this
type of haemoglobin in the protection of FA patients
against toxicity will be further studied.
In the present study, a significant inter-individual
variation in the experiments conducted in the pres-
ence of RBC, concerning the levels of chromosomal
damage, was observed for each donor, suggesting that
individual factors could be associated with a differ-
ential modulation of the levels of DNA damage after
exposure to DEB. Concerning the individual genetic
polymorphisms evaluated, GSTT1 is the only one asso-
ciated with the level of chromosomal damage induced
by DEB, the level of DNA damage observed being sig-
nificantly lower in ‘non-null’ individuals, suggesting
that this enzyme could be involved in the detoxifica-
tion of DEB. The fact that GSTT1 is not expressed in
human lymphocytes [25] can explain the absence of ef-
fects of GSTT1 on DEB genotoxicity in RBC-depleted
cultures, when compared with the significant effect
observed in whole blood cultures. The fact that all het-
erologous RBC added to RBC-depleted cultures were
from GSTT1 ‘non-null’ individuals can also explain
the significant decrease in chromosome breakage in
those cultures compared with whole blood cultures
where GSTT1 ‘null’ individuals are included. How-
ever, the inter-individual variation observed in these
experiments is not sufficient to explain the highly sig-
nificant variation in chromosome breakage between
whole blood and RBC-depleted cultures. So, other
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factors may be involved in DEB detoxification, and the
role of haemoglobin was demonstrated in this study.
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